Monopar Therapeutics Inc. (MNPR)
Monopar Presents Phase 2 ALXN1840 Data Demonstrating Liver Disease Stabilization and Neurologic Improvement in Treatment-Experienced Wilson Disease Patients at EASL 2026
KAMADA LTD. (KMDA)
Kamada Announces FDA Approval of its New In-House Rabies Virus Neutralization Testing Laboratory
OPTION CARE HEALTH, INC. (OPCH)
Option Care Health Awarded TIMEs Worlds Most Impactful Companies 2026 Ranking
ACTUATE THERAPEUTICS, INC. (ACTU)
Actuate Therapeutics Announces ASCO Poster Presentations Demonstrating Compelling Clinical and Biomarker Data for Elraglusib in First-Line Metastatic Pancreatic Cancer
C1 FUND INC. (CFND)
C1 Fund Inc. (NYSE: CFND) Announces First Quarter 2026 Results
ANFIELD ENERGY INC. (AEC)
Anfield Energy Inc. Completes Phase One Surface Construction at Velvet-Wood Project
LIFE TIME GROUP HOLDINGS, INC. (LTH)
Lithium Ionic Provides Bi-Weekly MCTO Status Update
GLOBAL PHARMATECH, INC. (OTCM)
OTC Markets Group Welcomes Unico Silver Ltd. to OTCQX
TRANSDIGM GROUP INC (TDG)
TDG Initiates Preliminary Economic Assessment for the Shasta Gold-Silver Project
MOBILEYE GLOBAL INC. (MBLY)
Mobileye Named Frost & Sullivan 2026 Company of the Year in Global Passenger Vehicle ADAS Industry